Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The benefit of the combination of serum galactomannan (GM) assay and polymerase chain reaction (PCR)-based detection of serum Aspergillus DNA for the early diagnosis and therapy of invasive aspergillosis (IA) in high-risk hematological patients remains unclear. METHODS: We performed an open-label, controlled, parallel-group randomized trial in 13 Spanish centers. Adult patients with acute myeloid leukemia and myelodysplastic syndrome on induction therapy or allogeneic hematopoietic stem cell transplant recipients were randomized (1:1 ratio) to 1 of 2 arms: "GM-PCR group" (the results of serial serum GM and PCR assays were provided to treating physicians) and "GM group" (only the results of serum GM were informed). Positivity in either assay prompted thoracic computed tomography scan and initiation of antifungal therapy. No antimold prophylaxis was permitted. RESULTS: Overall, 219 patients underwent randomization (105 in the GM-PCR group and 114 in the GM group). The cumulative incidence of "proven" or "probable" IA (primary study outcome) was lower in the GM-PCR group (4.2% vs 13.1%; odds ratio, 0.29 [95% confidence interval, .09-.91]). The median interval from the start of monitoring to the diagnosis of IA was lower in the GM-PCR group (13 vs 20 days; P = .022), as well as the use of empirical antifungal therapy (16.7% vs 29.0%; P = .038). Patients in the GM-PCR group had higher proven or probable IA-free survival (P = .027). CONCLUSIONS: A combined monitoring strategy based on serum GM and Aspergillus DNA was associated with an earlier diagnosis and a lower incidence of IA in high-risk hematological patients. Clinical Trials Registration. NCT01742026.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917 · cited 13×
“When the result of at least 1 of the tests informed to the clinicians turned to be positive (ie, serum GM and/or rtPCR in the GM-PCR group and solely the former in the GM group), ordering a thoracic high-resolution computed tomography (HRCT) scan was mandatory and an antifungal agent with activity against Aspergillus…”
BackgroundMethodInfluentialKontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
Mengoli, C., Cruciani, M., Barnes, R. A., Loeffler, J., & Donnelly, J. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70019-2 · Cited by 354 · cited 1×
“To increase the predictive positive value, an rtPCR assay result was considered positive in presence of ≥2 consecutive positive samples [25].”
BackgroundMarchetti, O., Lamoth, F., Mikulska, M., Viscoli, C., Verweij, P., Bretagne, S., & Groups, A. T. E. C. O. I. I. L. (. L. W. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.178 · Cited by 275
Montagna, M. T., Lovero, G., Coretti, C., Martinelli, D., Delia, M., De Giglio, O., Caira, M., Puntillo, F., D’Antonio, D., Venditti, M., et al. (2014) · Infection · doi:10.1007/s15010-013-0539-3 · Cited by 70
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“The use of galactomannan and βd-glucan to assist in the assessment of invasive aspergillus (and a broad range of fungal pathogens) has become well accepted [209, 210].”
BackgroundSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
“Clinical trials incorporating biomarkers into the management of adults with hematologic malignancies or allogeneic HSCT have shown that combined GM and PCR reduced use of antifungal treatment [80], and was associated with an earlier diagnosis and lower incidence of IA [81].”
BackgroundUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationSepsis and septic shock: Guideline-based management
Dugar, S., Choudhary, C., & Duggal, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.18143 · Cited by 229
Metadata
- Authors
- Aguado, J. M., Vazquez, L., Fernandez-Ruiz, M., Villaescusa, T., Ruiz-Camps, I., Barba, P., Silva, J. T., Batlle, M., Solano, C., Gallardo, D., Heras, I., Polo, M., Varela, R., Vallejo, C., Olave, T., Lopez-Jimenez, J., Rovira, M., Parody, R., Cuenca-Estrella, M., for the PCRAGA Study Group, the Spanish Stem Cell Transplantation Group, T. S. G. O. M. M. O. T. S. S. O. C. M. A. I. D., Zarzuela, M. P., Candel Gonzalez, F. J., Amador, P. M., Mediavilla, J. D., Camps, I. R., Barba, P., Castillo, N., Martin, M. T., Soriano, J. A., Fernando, I. H., Castilla-Llorente, C., Cesteros, R., Rodriguez Mondejar, M. R., Vazquez, L., Villaescusa, T., Caballero, D., Garcia, J. E., Garcia, I. G., de la Mano Gonzalez, S., Fernandez Garcia-Hierro, J. M., Solano, C., Tormo, M., Navarro, D., Angel Molla, M., Vallejo, C., Gonzalez, A. J., Gonzalez, S., Gonzalez, A. P., Palomo, P., Porras, R. P., Batlle, M., Gallardo, D., Guardia Sanchez, R., Rosario Varela, M., Olave Rubio, M. T., Jimenez, J. L., Tarrats, M. R., Grande, M. S.-L., Fernandez-Aviles, F., Aguado, J. M., Fernandez-Ruiz, M., Silva, J. T., Cuenca-Estrella, M., Buitrago, M. J., Amador, T. M., & Bernal-Martinez, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-21
- Volume
- 60
- Issue
- 3
- Pages
- 405-414
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2014423588
- Cited by
- 158
- References
- 5
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.